BackAkers Biosciences Overview

Akers Biosciences EBIT

EBIT (Earnings Before Interest and Taxes) analysis for AKER.

Quarterly EBIT

-$17.58M
1212.6% YoY

As of Dec 31, 2020

Annual EBIT (TTM)

-$19.76M
84.51% YoY

Trailing 12 months ending Dec 31, 2020

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)